Elranatamab: a new promising BispAb in multiple myeloma treatment.

Karolina KociszewskaMartyna Bednarczyk Sebastian Grosicki

Published in: Expert review of anticancer therapy (2023)

Currently, elranatamab is being investigated in a few clinical studies, and the preliminary results are very encouraging. At the time of writing this review there were no full papers published and all of the data in the literature were based on abstract presentations which carry limitations.

Keyphrases

multiple myeloma
systematic review
big data
randomized controlled trial
atomic force microscopy
combination therapy
machine learning
high resolution
deep learning